Jump to content

PsychENCODE Consortium

From Wikipedia, the free encyclopedia

The PsychENCODE Consortium was founded by the U.S. National Institutes of Health in 2015 to study the role of rare genetic variants involved in several psychiatric disorders. PsychENCODE aims to create a public resource of genomic data gathered from 1,000 healthy and disease-affected post-mortem brains reflecting different developmental periods.

PsychENCODE will first focus on autism spectrum disorder, bipolar disorder, and schizophrenia, and then move on to other disorders.[1]

Participating organizations

[edit]

As of December 2018, participating organizations include:

References

[edit]
  1. ^ Akbarian, S; Liu, C; Knowles, JA (2015). "The PsychENCODE project". Nat Neurosci. 18 (12): 1707–12. doi:10.1038/nn.4156. PMC 4675669. PMID 26605881.
  2. ^ "PsychENCODE". psychENCODE.org. Retrieved 2018-12-26.